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Abstract
Background Surgery remains the cornerstone of esophageal cancer treatment but is burdened with high procedure-related
morbidity. Anastomotic leakage as the most important surgical complication after esophagectomy is a key indicator for quality
in surgical outcome research.
Purpose The aim of this narrative review is to assess and summarize the current knowledge on prevention of anastomotic leakage
after esophagectomy and to provide orientation for the reader in this challenging field of surgery.
Conclusions There are various strategies to reduce postoperative morbidity and to prevent anastomotic leakage after esophagec-
tomy, including adequate patient selection and preparation, and many technical-surgical and anesthesiological details. The
scientific evidence regarding those strategies is highly heterogeneous, ranging from expert’s recommendations to randomized
controlled trials. This review is intended to serve as an empirical guideline to improve the clinical management of patients
undergoing esophagectomy with a special focus on anastomotic leakage prevention.
Keywords Esophagectomy . Anastomotic leakage . Prevention
Introduction
Despite significant progress in perioperative management,
esophagectomy for cancer remains a procedure with relevant
morbidity, even in high-volume centers [1, 2]. The spectrum
of postoperative morbidity after esophagectomy is broad, with
pulmonary and anastomotic complications being the most
common types [3–5].
Although different definitions and classifications [6] have
been described, anastomotic leakage (AL) is a key indicator
for surgical quality [1, 7] owing to its correlation with surgical
expertise [8] and its tremendous impact on postoperative out-
come. Sound surgical technique is key for proper anastomotic
healing; however, AL rates > 20% have been reported even by
renowned centers of expertise [9, 10]. Moreover, there is no
evidence that new technology such as minimally invasive and
robotic-assisted techniques would reduce the risk for AL.
Various strategies aim at prevention of AL, including prop-
er patient selection, preparation and prehabilitation programs,
techniques to improve and control vascularization of the gas-
tric conduit, and many surgical and anesthesiological details.
In this context, the aim of this narrative review was to sum-
marize the spectrum of these strategies and to comment on
their scientific evidence and clinical significance.
Patient selection and preparation
Neoadjuvant treatments, comorbidity, and age
Neoadjuvant chemotherapy or chemo-radiation followed by
surgery has become the standard of care in the treatment of
esophageal cancer [11, 12]. However, a recent large retrospec-
tive European multicenter study revealed a significantly
higher risk of postoperative complications including AL in
cardiorespiratory comorbid patients after neoadjuvant che-
mo-radiation, but not after neoadjuvant chemotherapy [13,
14]. Consequently, neoadjuvant chemo-radiation should be
employed with particular caution in patients with known re-
spiratory comorbidity [15].
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Numerous comorbidities are linked to increased AL risk
such as obesity, heart failure, coronary artery disease, periph-
eral vascular disease, hypertension, steroids, diabetes mellitus,
renal insufficiency, and tobacco use [16]. In addition, atrial
fibrillation [17] and COPD [18] are known independent risk
factors. Most comorbidities have a negative impact on micro-
vascular perfusion, and it has been hypothesized that arterio-
sclerosis may play an important role in the etiology of AL
[19]. Consequently, several retrospective cohort studies have
confirmed an association between AL and loco-regional post-
coeliac [20, 21] and aortic and coeliac trunk [22] calcifica-
tions. Moreover, others have evidenced an association be-
tween AL and supra-aortic and coronary arteriosclerosis
[18], implying that general radiological arteriosclerosis scores
may be useful to estimate the risk of AL [21, 23, 24].
Besides the abovementioned factors, age may play a major
role in postoperative morbidity as older patients have more
comorbidities and a reduced physiological resilience [25].
For example, older individuals have a higher probability of
new-onset atrial fibrillation after esophagectomy [26], which
is a known risk factor for pneumonia and AL. In addition, in
patients ≥ 75 years, the nutritional status is often impaired [27]
and the sarcopenia rate is higher [28, 29]. However, none of
the prospective cohort studies comparing younger (< 75 years)
and older (≥ 75) cohorts found an association between age and
postoperative morbidity or mortality [27, 30].
In summary, several secondary illnesses and comorbidities
play a pivotal role in patient outcome after esophagectomy. In
order to optimize preoperative assessment of esophageal can-
cer patients, prediction tools using readily available character-
istics have been suggested recently [31]. Careful patient selec-
tion and thorough navigation through risks and benefits re-
mains key for achieving optimal results.
Preoperative nutrition
Malnutrition is highly prevalent in patients with esophageal
carcinoma and has been linked to a higher incidence of AL in
GI-tract surgery [32]. Consequently, nutritional support prior
to surgery is associated with a reduced complication rate after
esophagectomy [33]. In this context, screening of the nutri-
tional status in patients scheduled for esophagectomy follow-
ing the ESPEN (European Society for Clinical Nutrition and
Metabolism) criteria is highly recommended [34]. Most ex-
perts agree that preoperative nutritional support is indicated if
body weight loss was ≥ 10–15% over the past 6 months, and
in patients with a BMI < 18.5 kg/m2 or a serum albumin <
30 g/l [34]. In addition, nutritionists should be involved to
monitor protein and calorie intake and to assess the need for
dietary supplements. In case of severe dysphagia, placement
of an enteral feeding tube and preoperative nutritional support
for a minimum of 7–14 days is recommended according to the
ESPEN guidelines [35, 36].
Perioperative dietary supplementation with immune-
stimulating nutrients (omega-3 fatty acids, arginine,
nucleotides) may reduce oxidative stress and inflammatory
response. Correspondingly, perioperative immunonutrition
was found to reduce postoperative morbidity in gastrointesti-
nal cancer surgery in a systematic review of randomized con-
trolled trials (RCTs) [37]. However, another recent meta-
analysis of RCTs with a specific focus on esophagectomy
did not confirm a positive effect of immunonutrition on AL,
overall morbidity, postoperative hospital stay, or immune in-
dices such as C-reactive protein, interleukin-6, IL-8, and tu-
mor necrosis factor-α [38]. Therefore, immunonutrition prior
to esophageal cancer surgery remains a controversial issue.
Prehabilitation
Prehabilitation is a relatively new concept that entails a variety
of preoperative measures to prepare patients for surgery.
Prehabilitation is part of enhanced recovery after surgery
(ERAS) protocols [39] and includes nutritional, physical,
and psychological components. The physical component of
prehabilitation programs entails inspiratory muscle training,
aerobic exercise, and general strengthening activities. The ef-
fect of preoperative inspiratory muscle training on postopera-
tive morbidity and AL rate remains controversial, although
most research points towards a beneficial effect. The use of
spirometers has been found to correlate positively with post-
operative pulmonary morbidity [40], and two RCTs and one
observational study have evidenced a reduction in severe pul-
monary [41, 42] and overall complications [43] through peri-
operative inspiratory muscle training. However, other ran-
domized studies could not confirm a benefit of inspiratory
muscle training [44].
Likewise, aerobic exercises and strengthening activities
during > 4 weeks prior to esophagogastric surgery had a pos-
itive impact on preoperative fitness tests, an effect that
sustained for 4–8 weeks after surgery [45]. Four RCTs on
prehabilitation programs in gastroesophageal carcinoma are
pending [46–49]. Interestingly, an RCT comparing the effect
of prehabilitation with postoperative rehabilitation after colo-
rectal cancer surgery evidenced that a 4-week prehabilitation




Anesthesiological measures focus on lung-protective ventila-
tion, fluid management, and analgesia [51]. Restrictive peri-
operative fluid management has been recommended to reduce
the rate of pulmonary complications and AL [51, 52].
However, excessive fluid restriction may cause hypovolemia,
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hypotension, and need for catecholamines, thus increasing the
risk for ischemia and AL [6]. Similarly, epidural anesthesia
has become an integral part of ERAS programs [53] and rep-
resents the standard of care for perioperative pain control in
many centers. However, epidural analgesia causes periopera-
tive hypotension in 20–76% of patients and has been directly
associated with AL [54]. Therefore, standardized continuous
monitoring of perioperative hemodynamics is pivotal to coun-
terbalance potential drawbacks of esophagectomy-specific
anesthesiological management [52].
Surgical-technical aspects
Intrathoracic versus cervical anastomosis
There is a long-standing debate whether the anastomosis after
gastric pull-up procedure should be placed in the neck or
intrathoracically. Most RCTs [55–58], retrospective cohort
studies [2, 59, 60], and metaanalyses [21] show higher leak
and recurrent nerve palsy rates but a reduced leak-associated
morbidity after cervical anastomosis [4, 55, 60, 61]. The
higher leak rate in cervical anastomoses might be caused by
greater tension and placement in the gastric fundus (with po-
tentially impaired vascular supply), whereas intrathoracic
esophagogastrostomies are constructed under less longitudi-
nal stress in a more distal and better-perfused gastric area [7,
62]. On the other hand, management of cervical AL is more
straightforward and potentially less life threatening than intra-
thoracic AL. Interestingly however, a recent international sur-
vey among specialized surgeons has evidenced a strong ten-
dency towards intrathoracic reconstructions [63], presumably
owing to the substantial improvements regarding anastomotic
leak management over the last years [64].
Gastric tube formation
Intestinal continuity after esophageal resection is typically re-
stored using the whole stomach or a gastric tube. However,
there is still considerable debate about the ideal type of con-
duit. The rationale for using a wide gastric tube or even the
whole stomach was established more than 50 years ago by
Levasseur and Couinaud [65] who showed that the intramural
gastric vascular network originating from the left gastric artery
connects the right and left gastroepiploic perfusion areas be-
tween antrum and fundus. This finding was later confirmed in
autopsy studies [66, 67]. Accordingly, removal of the lesser
curvature during gastric tubulization may induce ischemia of
the upper part of the stomach and increase the risk for AL.
With this in mind, others [68] have suggested to only remove
the upper part of the greater curvature and to place the staple-
line close to the lesser curvature in order to preserve as much
intramural vascular network as possible. Jean-Marie Collard,
from the same point of view, found that vascular and lymphat-
ic denudation of the lesser curvature provides a similar length-
ening effect without destruction of the intramural vascular
network and advocated the whole stomach as best option for
esophagogastric reconstruction with lower AL rate and supe-
rior function [67]. However, this concept has been challenged,
arguing that a long and narrow gastric tube could reduce the
incidence of AL owing to lower anastomotic tension. In sum-
mary, there is conflicting data in the literature regarding AL
rate after narrow and wide gastric tube or whole stomach
reconstructions. A recent meta-analysis found a similar AL
rate, but a higher incidence of gastroesophageal reflux and
thoracic stomach syndrome after whole stomach reconstruc-
tion [69]. Accordingly, most experts currently use a relatively
broad (4–5 cm) gastric tube [70].
Anastomotic technique
Many different techniques have been devised for reconstruc-
tion after esophagectomy: (semi)mechanical or hand-sewn,
linear-stapled, circular-stapled and double-stapled, end-to-
side, side-to-side, single-row, and double-row techniques.
Moreover, the number of individual variations is legion owing
to different suture materials and stapling devices, and the man-
ifold individual technical steps taken by each surgeon. In ad-
dition, with the advent of minimally invasive esophagectomy,
adjustments and modifications of existing techniques and
even completely new designs have been developed [63].
A recent metaanalysis [71] showed similar AL rates in end-
to-side circular-stapled and side-to-side linear-stapled
esophagogastrostomy. In contrast, AL rates after side-to-side
linear-stapled esophagogastrostomy were lower compared
with the end-to-side hand-sewn technique for cervical, but
not for intrathoracic, anastomoses [72]. Consistently, both
studies revealed a lower rate of anastomotic stenosis of side-
to-side linear-stapled techniques, but the significance of these
results remains doubtful owing to a lack of uniform definitions
of AL and stricture.
In a large retrospective multicenter study including 966
patients that underwent minimally invasive thoracoscopic-
laparoscopic esophagectomy, leakage rates after intrathoracic
end-to-side double-stapling (23.3%) and cervical end-to-side
hand-sewn (25.1%) techniques were significantly higher com-
pared with intrathoracic side-to-side linear (15.6%), end-to-
side purse-string (13.9%), and cervical side-to-side linear-
stapled esophagogastrostomy (11.8%) [7]. Multivariable anal-
ysis confirmed anastomotic technique as independent predic-
tor of leakage. However, the authors concluded that the above
results require cautious interpretation considering the long
learning curve of minimally invasive esophagectomy. In con-
clusion, the scientific evidence on this topic remains weak and
superiority of certain techniques in terms of leakage rate is
questionable. Therefore, a surgeon’s choice of a specific
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anastomotic design remains mainly based on personal experi-
ence rather than on solid scientific proof.
Additional surgical measures
Pedicled omental flaps have proven their usefulness in the
management of complex thoracic and abdominal fistula.
After esophagectomy, the upper part of the omentum along
the gastric fundus can easily bewrapped around and sutured to
the anastomosis [73]. This technical maneuver may be used in
both cervical and intrathoracic anastomosis [74]. The well-
perfused fatty tissue provides ample supply of nutrition and
oxygen to the anastomotic area including secretion of vascular
endothelial growth factor for enhanced angiogenesis and ox-
ygenation [75]. In case of leakage, the omental flap may cover
the defect by creating a contained situation that prevents free
leakage to the mediastinum.
Numerous studies including a recent meta-analysis of ran-
domized trials [76] have evaluated omental wrapping with
positive results, and most specialist surgeons endorse this ad-
junct to improve healing of esophagogastric reconstructions.
With a similar rationale, many surgeons recommend to
suture the mobilized pleura over the completed anastomosis
[77]. “Pleural tenting”may be applied in combination with an
omental wrap or as a single additional maneuver. However, to
our best knowledge, this procedure has not been evaluated in
comparative studies and remains a topic in need of further
investigation.
Excessive tension at the anastomosis may occur in case of
an incomplete vascular arcade, previous gastric surgery, or in
very high cervical anastomoses. In these situations, additional
length of the gastric tube can be gained by division of the
peritoneal reflection of the hepatoduodenal ligament and by
extensive duodenal mobilization (Kocher’s maneuver). These
techniques are particularly helpful if the distance between py-
lorus and hiatus remains too large after gastric mobilization
[78]. In extreme cases, division of the branches of the right
gastric artery, or even duodenal [79] or pyloric [80] diversion
on a jejunal limb may generate extra mobility. Similarly, lon-
gitudinal [81] or circular [82] incision of the gastric serosa has
been described to achieve additional length. However, we are
not aware of any research on this topic and indications remain
entirely based on individual experience.
Intraoperative perfusion monitoring
Assessment of the viability of the neo-esophagus usually re-
lies on the surgeon’s subjective evaluation. Typical signs of a
healthy gastric tube include rosy-colored tissues, a pulsating
vascular arcade, and active bleeding from the staple line or the
upper part of the omentum. However, local ischemia at the tip
of the gastric interponate is a frequent finding after gastric
mobilization. Ischemia may depend on vascularization and
other factors such as vasoconstriction, fluid management, cat-
echolamine dosage, and the patient’s hemodynamic situation.
Therefore, a range of innovative tools for assessment of gas-
tric tube viability has been developed over the last years: Laser
Doppler flowmetry, near infrared spectroscopy, optical coher-
ence tomography, and laser speckle contrast, infrared thermo-
graphic, fluorescence, and hyperspectral imaging [83].
Preliminary results of retro- and prospective cohort studies
have shown promising results [84], and some of these tools
have become commercially available. Perfusion monitoring is
a promising technique, and a literature review has evidenced a
significant benefit regarding AL rate [85]. Various questions
remain albeit unanswered because many technical solutions
still rely on subjective assessment, and no general agreement
on perfusion parameters, normal values, thresholds, or quan-
titative validation has been established. Therefore, the current
evidence supporting a routine intraoperative use of perfusion
monitoring is still pending, and further research is required to
fully explore its clinical potential.
Ischemic conditioning
Partial gastric devascularization prior to esophagectomy is a
relatively new concept in esophageal surgery. The idea of
ischemic conditioning is to optimize the gastric blood flow
in preparation for later esophagectomy through preoperative
selective occlusion of the left gastric ± short gastric arteries.
Arterial occlusion is accomplished by either surgical ligation
or interventional embolization [86]. The resulting relative is-
chemia is expected to resolve via hemodynamic redistribution
from the remaining vessels, thus avoiding ischemia during
later reconstruction. In addition, gastric devascularization
may lead to a demarcation of ischemic areas, facilitating the
choice of the best location for anastomotic reconstruction [87].
Shortcomings of gastric conditioning include the need for ad-
ditional resources, increased cost [88], and adhesion formation
complicating subsequent gastric mobilization and lymphade-
nectomy [89, 90]. Ischemic conditioning has been investigat-
ed in prospective and retrospective cohort studies including
several RCTs [86]. Owing to divergent technical approaches,
it is very difficult to draw conclusions. However, two recent
meta-analyses of the current literature did not reveal a signif-
icant impact on AL rates [86, 88]. Therefore, many early ad-
vocates have abandoned ischemic conditioning in routine
cases and reserve this option for high-risk patients that might
benefit from a two-stage approach [91].
Gastric decompression
According to Laplace’s law, the wall tension in a cylindrical
vessel increases with greater radius and higher luminal pres-
sure (wall tension = pressure × radius). By applying basic
physics to surgical practice, the intramural strain of a dilated
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gastric tube will be higher than in a properly drained
interponate. Accordingly, insufficient postoperative gastric
decompression may cause impaired blood perfusion, reduced
oxygen supply, and a higher risk for AL or even gastric tube
necrosis. Another potential benefit of gastric decompression is
the prevention of regurgitation and aspiration. Therefore, most
specialists rely on routine postoperative drainage of the con-
duit. On the other hand, prolonged gastric drainage may inter-
fere with ERAS programs through delayed oral feeding with
longer hospital stay and increased cost. In addition, nasogas-
tric drains may cause discomfort and can also induce aspira-
tion [92]. Therefore, some surgeons prefer percutaneous
transcervical [93] or retrograde [94, 95] (via drain-
jejunostomy) conduit decompression. To untangle potential
associations between postoperative conduit drainage and
complications, numerous studies including several RCTs have
been conducted with divergent results. A recent review on
preoperative, early or late postoperative removal of gastric
drains revealed no effect on AL rate, pulmonary complica-
tions, or mortality [96]. However, the current evidence re-
mains weak owing to small sample sizes and the heterogeneity
of the available evidence. In addition, comparability is further
limited due to different techniques of luminal decompression,
including single- or double-lumen (sump-)tubes with or with-
out application of varying negative pressure.
Preemptive vacuum therapy
Treatment of AL has considerably progressed in recent years,
and surgical revision has been largely replaced by interven-
tional procedures. In addition to stent placement, endoluminal
vacuum therapy (EVT) has become the treatment of choice in
many specialized centers [64]. In EVT, a polyurethane sponge
connected to a hose is brought to the anastomotic area via
endoscopy. After vacuum application, the sponge drains the
leakage cavity and removes secretions and necrosis,
accomplishing an 80–90% healing rate [97].
A novel idea is to use the EVT technology in a preemptive
setting, with the aim of preventing AL and reducing postop-
erative morbidity. In a recent case series, early EVT in patients
with anastomotic ischemia was effective in six of eight esoph-
agectomy patients [98]. Likewise, in a porcine model, intra-
operative application of EVT in esophagogastric anastomoses
with intentional 1 cm defects resulted in complete healing
[99]. Considering the high incidence of AL, we have recently
implemented preemptive EVT (pEVT) in patients undergoing
esophagectomy and gastric tube reconstruction. Initial results
were promising with a low leakage rate of 5% [100]. Since
then, we have used pEVT with a persistently low AL rate in
more than 80 cases. In the rare event of AL, clinical courses
were generally mild and without septic complications. Based
on this positive experience, we have designed an international
multicenter RCT (NCT04162860). The aim of this project is
to prove whether pEVT may reduce AL rates and overall
morbidity after minimally invasive esophagectomy.
Comment
Anastomotic leakage after esophagectomy is a severe compli-
cation with potentially devastating consequences. A wide
range of measures to prevent AL has been suggested
encompassing everything from adequate patient selection
and prehabilitation over surgical training to many details of
the operative procedure and perioperative management.
Unfortunately, the quality of clinical research is highly vari-
able and only few interventions are supported by strong evi-
dence. Therefore, even in high-volume centers, both preven-
tion and management of AL are mostly guided by empiric
observation, pragmatism, and personal experience rather than
based on solid scientific evidence.
The current lack of standardized definitions for key criteria
of surgical quality outcome remains a major issue. As an ex-
ample, there are more than 50 different definitions for anasto-
motic leakage [101–103] leaving much room for interpreta-
tion and impeding objective surgical outcome research. In this
context, the definitions and classifications of complications
after esophagectomy elaborated by the ECCG are a major step
in the right direction [104] but may still take time to gain wide
acceptance.
Since various comorbidities are clearly linked to increased
AL incidence, selection of appropriate candidates for surgery
might be the most efficient way to reduce postoperative mor-
bidity. However, in many departments, functional evaluation
of patients scheduled for esophagectomy is still arbitrary with-
out clear guidelines. Therefore, both straightforward and ac-
curate predictive tools are urgently needed. In this context, the
introduction of simple nomograms using readily available
clinical parameters to predict complication risks may gain
acceptance in the future [31].
Surgical expertise, operative skills, and the use of state-
of-the-art technique are the basic ingredients required for a
successful esophageal cancer surgery program. Of note,
minimally invasive esophagectomy has an extremely long
learning curve of more than 100 cases until acceptable post-
operative morbidity may be attained [8]. The effect of sur-
gical learning on outcome has been shown based on oper-
ative time, overall morbidity and AL rate, percentage of
textbook outcomes, and the number of resected lymph
nodes [105–111]. Therefore, centralization of esophageal
surgery in order to increase case numbers per center is piv-
otal to reduce the morbidity of this demanding procedure.
In addition, learning curricula, proctoring programs, fel-
lowships, and specialized courses with specific training in
esophagectomy should be strongly encouraged.
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